{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T14:28:43Z","timestamp":1768314523709,"version":"3.49.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research (ICMR)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.vaccine.2013.04.005","type":"journal-article","created":{"date-parts":[[2013,4,28]],"date-time":"2013-04-28T09:15:35Z","timestamp":1367140535000},"page":"3818-3825","source":"Crossref","is-referenced-by-count":13,"title":["Role of MHC class Ib molecule, H2-M3 in host immunity against tuberculosis"],"prefix":"10.1016","volume":"31","author":[{"given":"Shabir Ahmad","family":"Mir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadhna","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2013.04.005_bib0005","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S1472-9792(12)70005-7","article-title":"Tuberculosis vaccines: a strategic blueprint for the next decade","volume":"92","author":"Brennan","year":"2012","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0010","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/infdis\/167.6.1481","article-title":"T cell response to Mycobacterium tuberculosis","volume":"167","author":"Orme","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0015","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev.iy.09.040191.001415","article-title":"The dendritic cell system and its role in immunogenicity","volume":"9","author":"Steinman","year":"1991","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1084\/jem.183.1.7","article-title":"Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity","volume":"183","author":"Young","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0025","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1146\/annurev.iy.12.040194.004203","article-title":"Antigen presentation by major histocompatibility complex class I-B molecules","volume":"12","author":"Shawar","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0030","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0092-8674(91)90623-7","article-title":"H-2M3 encodes the MHC class I molecule presenting the maternally transmitted antigen of the mouse","volume":"66","author":"Wang","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1074-7613(00)80311-8","article-title":"A Listeria monocytogenes pentapeptide is presented to cytolytic T lymphocytes by the H2-M3 MHC class Ib molecule","volume":"5","author":"Gulden","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1074-7613(00)80310-6","article-title":"Identification of an H2-M3-restricted Listeria epitope: implications for antigen presentation by M3","volume":"5","author":"Lenz","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0045","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1084\/jem.187.10.1711","article-title":"H2-M3 restricted presentation of a Listeria-derived leader peptide","volume":"187","author":"Princiotta","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0050","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1054\/tuld.1999.0226","article-title":"Immunization with f-Met peptides induces immune reactivity against Mycobacterium tuberculosis","volume":"80","author":"Dow","year":"2000","journal-title":"Tuberc Lung Dis"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0055","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.4049\/jimmunol.178.6.3806","article-title":"H2-M3-restricted CD8+ T cells induced by peptide-pulsed dendritic cells confer protection against Mycobacterium tuberculosis","volume":"178","author":"Doi","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0060","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.193.10.1213","article-title":"Induction of M3-restricted cytotoxic T lymphocyte responses by N-formylated peptides derived from Mycobacterium tuberculosis","volume":"193","author":"Chun","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0065","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/79631","article-title":"Is the development of a new tuberculosis vaccine possible?","volume":"6","author":"Kaufmann","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0070","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/35095558","article-title":"How can immunology contribute to the control of tuberculosis?","volume":"1","author":"Kaufmann","year":"2001","journal-title":"Nat Rev Immunol"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2013.04.005_bib0540","doi-asserted-by":"crossref","first-page":"ii50","DOI":"10.1136\/ard.2004.028258","article-title":"New issues in tuberculosis","volume":"63","author":"Kaufmann","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrmicro749","article-title":"Tuberculosis: a problem with persistence","volume":"1","author":"Stewart","year":"2003","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0080","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","article-title":"Cell-mediated immune responses in tuberculosis","volume":"27","author":"Cooper","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0085","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.micinf.2005.03.008","article-title":"The use of animal models to guide rational vaccine design","volume":"7","author":"Orme","year":"2005","journal-title":"Microbes Infect\/Inst Pasteur"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0090","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1073\/pnas.95.1.270","article-title":"Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis","volume":"95","author":"Lalvani","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0095","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","article-title":"Immunology of tuberculosis","volume":"19","author":"Flynn","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0100","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1073\/pnas.97.8.4204","article-title":"Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice","volume":"97","author":"Sousa","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0105","doi-asserted-by":"crossref","first-page":"12013","DOI":"10.1073\/pnas.89.24.12013","article-title":"Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection","volume":"89","author":"Flynn","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0110","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4049\/jimmunol.138.1.293","article-title":"The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis","volume":"138","author":"Orme","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0115","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin","volume":"115","author":"Grode","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0120","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/infdis\/jir592","article-title":"Recombinant BCG \u0394ureC hly+induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responses","volume":"204","author":"Desel","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0125","doi-asserted-by":"crossref","first-page":"e1000392","DOI":"10.1371\/journal.ppat.1000392","article-title":"A critical role for CD8 T cells in a nonhuman primate model of tuberculosis","volume":"5","author":"Chen","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0130","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/ni1008-1101","article-title":"Tuberculosis: unsealing the apoptotic envelope","volume":"9","author":"Porcelli","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0135","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.cell.2007.05.059","article-title":"Tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells","volume":"129","author":"van der Wel","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0145","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.immuni.2005.12.001","article-title":"Apoptotic vesicles cross prime CD8 T cells and protect against tuberculosis","volume":"24","author":"Winau","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0150","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nm1257","article-title":"Accelerated CD8+ T cell memory and prime-boost response after dendritic-cell vaccination","volume":"11","author":"Badovinac","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0155","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.4049\/jimmunol.169.9.4936","article-title":"Quantitation of CD8+ T cell expansion, memory, and protective immunity after immunization with peptide-coated dendritic cells","volume":"169","author":"Hamilton","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0160","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1172\/JCI0215962","article-title":"Exploiting dendritic cells to improve vaccine efficacy","volume":"109","author":"Steinman","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0165","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/j.vaccine.2005.11.026","article-title":"Immunization with dendritic cells retrovirally transduced with mycobacterial antigen 85A gene elicits the specific cellular immunity including cytotoxic T-lymphocyte activity specific to an epitope on antigen 85A","volume":"24","author":"Nakano","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0170","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.ymthe.2005.10.018","article-title":"Development of cell-based tuberculosis vaccines: genetically modified dendritic cell vaccine is a much more potent activator of CD4 and CD8 T cells than peptide- or protein-loaded counterparts","volume":"13","author":"Malowany","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0175","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1128\/IAI.70.3.1623-1626.2002","article-title":"Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T cell epitopes from antigen 85A","volume":"70","author":"McShane","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0180","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nri1592","article-title":"Dendritic cells as therapeutic vaccines against cancer","volume":"5","author":"Banchereau","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0185","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.immunol.21.120601.141114","article-title":"CD8 T cell responses to infectious pathogens","volume":"21","author":"Wong","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0190","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nri1635","article-title":"MHC class Ib molecules bridge innate and acquired immunity","volume":"5","author":"Rodgers","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0195","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1054\/tuld.1999.0226","article-title":"Immunization with f-Met peptides induces immune reactivity against Mycobacterium tuberculosis","volume":"80","author":"Dow","year":"2000","journal-title":"Tuberc Lung Dis"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0200","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0092-8674(95)90037-3","article-title":"Nonclassical binding of formylated peptide in crystal structure of the MHC class Ib molecule H2-M3","volume":"82","author":"Wang","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0205","doi-asserted-by":"crossref","first-page":"F35","DOI":"10.1084\/jem.193.10.F35","article-title":"CD8 T cell detection of bacterial infection: sniffing for formyl peptides derived from Mycobacterium tuberculosis","volume":"193","author":"Lauvau","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0210","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nri2191","article-title":"CD1 antigen presentation: how it works","volume":"7","author":"Barral","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0215","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.imbio.2007.10.006","article-title":"Innate immune functions of human gammadelta T cells","volume":"213","author":"Beetz","year":"2008","journal-title":"Immunobiology"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0220","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nri2781","article-title":"Gammadelta T Cell effector functions: a blend of innate programming and acquired plasticity","volume":"10","author":"Bonneville","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0225","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00005-009-0017-x","article-title":"Antigen-restricted gammadelta T-cell receptors?","volume":"57","author":"Born","year":"2009","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0230","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.clim.2005.04.005","article-title":"Immune regulation of gammadelta T cell responses in mycobacterial infections","volume":"116","author":"Chen","year":"2005","journal-title":"Clin immunol (Orlando, Fla)"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0235","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/ni814","article-title":"Positive selection of MHC class Ib-restricted CD8(+) T cells on hematopoietic cells","volume":"3","author":"Urdahl","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0240","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4049\/jimmunol.171.1.291","article-title":"Class Ia MHC-deficient BALB\/c mice generate CD8+ T cell-mediated protective immunity against Listeria monocytogenes infection","volume":"171","author":"D\u2019Orazio","year":"2003","journal-title":"J Immunol (Baltimore, MD: 1950)"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0245","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.4049\/jimmunol.170.4.1987","article-title":"CD8+ T cells accumulate in the lungs of Mycobacterium tuberculosis-infected Kb\u2212\/\u2212Db\u2212\/\u2212 mice, but provide minimal protection","volume":"170","author":"Urdahl","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0250","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.4049\/jimmunol.162.9.5429","article-title":"Response to Listeria monocytogenes in mice lacking MHC class Ia molecules","volume":"162","author":"Seaman","year":"1999","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0255","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1084\/jem.181.5.1817","article-title":"H-2M3a violates the paradigm for major histocompatibility complex class I peptide binding","volume":"181","author":"Vyas","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0260","doi-asserted-by":"crossref","first-page":"9952","DOI":"10.1021\/bi0346446","article-title":"Characterization of a human peptide deformylase: implications for antibacterial drug design","volume":"42","author":"Nguyen","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0265","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4049\/jimmunol.161.1.90","article-title":"H2-M3 presents a nonformylated viral epitope to CTLs generated in vitro","volume":"161","author":"Byers","year":"1998","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0270","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.4049\/jimmunol.167.3.1507","article-title":"Functional roles of TAP and tapasin in the assembly of M3-N-formylated peptide complexes","volume":"167","author":"Chun","year":"2001","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0275","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1084\/jem.190.3.423","article-title":"The majority of H2-M3 is retained intracellularly in a peptide-receptive state and traffics to the cell surface in the presence of N-formylated peptides","volume":"190","author":"Chiu","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0280","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.4049\/jimmunol.162.11.6341","article-title":"Antigen secreted from noncytosolic Listeria monocytogenes is processed by the classical MHC class I processing pathway","volume":"162","author":"Zwickey","year":"1999","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0285","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.4049\/jimmunol.165.8.4575","article-title":"Partially TAP-independent protection against Listeria monocytogenes by H2-M3-restricted CD8+ T cells","volume":"165","author":"Rolph","year":"2000","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0290","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.4049\/jimmunol.167.4.2097","article-title":"Tapasin enhances peptide-induced expression of H2-M3 molecules, but is not required for the retention of open conformers","volume":"167","author":"Lybarger","year":"2001","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0295","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/jlb.51.5.472","article-title":"Mycobacterial infection primes T cells and macrophages for enhanced recruitment of neutrophils","volume":"51","author":"Appleberg","year":"1992","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0300","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","article-title":"Immunology of tuberculosis","volume":"19","author":"Flynn","year":"2001","journal-title":"Annu Rev Immunnol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0305","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1164\/ajrccm\/141.2.471","article-title":"Macrophages and polymorphonuclear neutrophils in lung defense and injury","volume":"141","author":"Sibille","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0310","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/jlb.55.5.676","article-title":"Cytokines and tuberculosis","volume":"55","author":"Wallis","year":"1994","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0315","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1172\/JCI117702","article-title":"Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components","volume":"95","author":"Zhang","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0320","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature09247","article-title":"An interferon-induced neutrophil-driven blood transcriptional signature in human tuberculosis","volume":"466","author":"Berry","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0325","first-page":"273","article-title":"Neutrophil participation in early control and immune activation during experimental pulmonary tuberculosis","volume":"142","author":"Barrios-Payan","year":"2006","journal-title":"Gac Med Mex"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0330","doi-asserted-by":"crossref","first-page":"e50345","DOI":"10.1371\/journal.pone.0050345","article-title":"Azurophil granule proteins constitute the major mycobactericidal proteins in human neutrophils and enhance the killing of mycobacteria in macrophages","volume":"7","author":"Jena","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0335","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2249.1991.tb05620.x","article-title":"Host and bacterial factors control the Mycobacterium avium induced chronic peritoneal granulocytosis in mice","volume":"83","author":"Appleberg","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0340","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/IAI.68.2.577-583.2000","article-title":"Neutrophil play a protective non-phagocytic role in systemic Mycobacterium tuberculosis infection of mice","volume":"68","author":"Pedrosa","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0345","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1172\/JCI31097","article-title":"Neutrophil-mediated innate immune resistance to mycobacteria","volume":"117","author":"Martineau","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0350","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.4049\/jimmunol.1103346","article-title":"Cathepsin G and neutrophil elastase contribute to lung protective immunity against mycobacterial infection in mice","volume":"188","author":"Steinwede","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0355","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1002\/eji.200323956","article-title":"Early granuloma formation after aerosol Mycobacterium tuberculosis infection is regulated by neutrophil via CXCR3-signaling chemokines","volume":"33","author":"Seiler","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0360","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/infdis\/162.3.700","article-title":"Killing of Mycobacterium tuberculosis by neutrophil: a non-oxidative process","volume":"162","author":"Jones","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0365","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.chom.2012.07.009","article-title":"Neutrophils exert protection in the early tuberculous granuloma by oxidative killing of mycobacteria phagocytosed from infected macrophages","volume":"12","author":"Yang","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0370","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1128\/AAC.45.2.639-640.2001","article-title":"Therapeutic potential of human neutrophil peptide-1 against experimental tuberculosis","volume":"45","author":"Sharma","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0375","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.4049\/jimmunol.179.4.2060","article-title":"Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on induction of cathelicidin","volume":"179","author":"Liu","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0380","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/science.282.5386.121","article-title":"An antimicrobial activity of cytolytic T cells mediated by granulysin","volume":"282","author":"Stenger","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0385","first-page":"391","article-title":"Expression of peroxidase-dependent iodination by macrophages ingesting neutrophil debris","volume":"28","author":"Heifets","year":"1980","journal-title":"J Reticuloendothel Soc"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0390","doi-asserted-by":"crossref","first-page":"864","DOI":"10.4049\/jimmunol.177.3.1864","article-title":"Macrophages acquire neutrophil granule for antimicrobial activity against intracellular pathogens","volume":"177","author":"Tan","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0395","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1034\/j.1600-065X.2000.917309.x","article-title":"Innate immune recognition: mechanisms and pathways","volume":"173","author":"Medzhitov","year":"2000","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0400","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/08923979909007117","article-title":"Cellular responses to FMLP challenging: a mini-review","volume":"21","author":"Panaro","year":"1999","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0405","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0092-8674(92)90097-V","article-title":"H-2M3 presents a Listeria monocytogenes peptide to cytotoxic T lymphocytes","volume":"70","author":"Pamer","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0410","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0923-2494(97)85218-2","article-title":"Class Ib MHC products in host immunity against Listeria monocytogenes","volume":"147","author":"Kurlander","year":"1996","journal-title":"Res Immunol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0415","doi-asserted-by":"crossref","first-page":"10896","DOI":"10.1073\/pnas.1834449100","article-title":"HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes","volume":"100","author":"Pietra","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0420","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.4049\/jimmunol.173.9.5852","article-title":"Identification of a human HLA-E-restricted CD8+ T cell subset in volunteers immunized with salmonella enterica serovar typhi strain Ty21a typhoid vaccine","volume":"173","author":"Salerno-Gon\u00e7alves","year":"2004","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0425","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.4049\/jimmunol.179.6.3947","article-title":"CD8+ T cell protective immunity against Chlamydia pneumoniae includes an H2-M3-restricted response that is largely CD4+ T cell-independent","volume":"179","author":"Tvinnereim","year":"2007","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0430","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1084\/jem.20051866","article-title":"Impaired response to Listeria in H2-M3-deficient mice reveals a nonredundant role of MHC class Ib-specific T cells in host defense","volume":"203","author":"Xu","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0435","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1084\/jem.190.2.195","article-title":"H2-M3-restricted T cells in bacterial infection: rapid primary but diminished memory responses","volume":"190","author":"Kerksiek","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0440","doi-asserted-by":"crossref","first-page":"5192","DOI":"10.4049\/jimmunol.165.9.5192","article-title":"MHC class Ib-restricted CTL provide protection against primary and secondary Listeria monocytogenes infection","volume":"165","author":"Seaman","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0445","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/195701b0","article-title":"Actinonin: an antibiotic substance produced by an actinomycete","volume":"195","author":"Gordon","year":"1962","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0450","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1021\/bi992245y","article-title":"Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor","volume":"39","author":"Chen","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0455","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1128\/AAC.47.8.2545-2550.2003","article-title":"Subinhibitory concentrations of the deformylase inhibitor actinonin increase bacterial release of neutrophil-activating peptides: a new approach to antimicrobial chemotherapy","volume":"47","author":"Fu","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0460","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-4758(99)01627-0","article-title":"Peptide deformylase of eukaryotic protists: a target for new antiparasitic agents?","volume":"16","author":"Meinnel","year":"2000","journal-title":"Parasitol Today (Personal ed)"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0465","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.4049\/jimmunol.181.2.1429","article-title":"Identification of formyl peptides from Listeria monocytogenes and Staphylococcus aureus as potent chemoattractants for mouse neutrophils","volume":"181","author":"Southgate","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0470","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijantimicag.2009.04.005","article-title":"In vitro and ex vivo activity of peptide deformylase inhibitors against Mycobacterium tuberculosis H37Rv","volume":"34","author":"Sharma","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0475","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jinf.2010.03.009","article-title":"Therapeutic potential of peptide deformylase inhibitors against experimental tuberculosis","volume":"60","author":"Sharma","year":"2010","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0480","unstructured":"Anthony Nolan Research Institute. HLA class I and class II sequence alignments, June 2009 updates. http:\/\/www.anthonynolan.org.uk\/research\/hlainformatics group 2009."},{"key":"10.1016\/j.vaccine.2013.04.005_bib0485","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1002\/eji.200535343","article-title":"Identification of effector-memory CMV-specific T lymphocytes that kill CMV-infected target cells in an HLA-E-restricted fashion","volume":"35","author":"Mazzarino","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0490","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1084\/jem.20020609","article-title":"HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cells","volume":"196","author":"Heinzel","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0495","doi-asserted-by":"crossref","first-page":"925","DOI":"10.4049\/jimmunol.165.2.925","article-title":"Mycobacterium tuberculosis-reactive CD8+ T lymphocytes: the relative contribution of classical versus nonclassical HLA restriction","volume":"165","author":"Lewinsohn","year":"2000","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0500","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4049\/jimmunol.166.1.439","article-title":"Classically restricted human CD8+ T lymphocytes derived from Mycobacterium tuberculosis-infected cells: definition of antigenic specificity","volume":"166","author":"Lewinsohn","year":"2001","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0505","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1164\/rccm.200306-837OC","article-title":"Mycobacterium tuberculosis-specific CD8+ T cells preferentially recognize heavily infected cells","volume":"168","author":"Lewinsohn","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0510","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1002\/1521-4141(200112)31:12<3687::AID-IMMU3687>3.0.CO;2-C","article-title":"The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha\/beta-mediated recognition","volume":"31","author":"Pietra","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0515","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/1521-4141(200204)32:4<936::AID-IMMU936>3.0.CO;2-M","article-title":"Human T cell receptor-mediated recognition of HLA-E","volume":"32","author":"Garc\u00eda","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0520","doi-asserted-by":"crossref","first-page":"e1000782","DOI":"10.1371\/journal.ppat.1000782","article-title":"Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T cells with cytotoxic as well as regulatory activity","volume":"6","author":"Joosten","year":"2010","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0525","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/34929","article-title":"HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes","volume":"391","author":"Collins","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0530","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1074-7613(00)80065-5","article-title":"The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells","volume":"10","author":"Cohen","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2013.04.005_bib0535","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S1473-3099(06)70656-9","article-title":"HIV-1 infection of mononuclear phagocytic cells: the case for bacterial innate immune deficiency in AIDS","volume":"6","author":"Noursadeghi","year":"2006","journal-title":"Lancet Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13004246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13004246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T06:48:00Z","timestamp":1745995680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13004246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":107,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0264410X13004246"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.04.005","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}